Genesee Capital Advisors, LLC Baxter International Inc Transaction History

Genesee Capital Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 29, 2020	SELL	$78.33 - $90.73 $1.51 Million - $1.75 Million	-19,247 Closed	0 $0
Q2 2020 Jul 20, 2020	SELL	$78.66 - $94.14 $101,078 - $120,969	-1,285 Reduced 6.26%	19,247 $1.66 Million
Q1 2020 Apr 16, 2020	SELL	$71.57 - $93.3 $112,937 - $147,227	-1,578 Reduced 7.14%	20,532 $1.67 Million
Q4 2019 Jan 14, 2020	SELL	$76.7 - $88.45 $21,476 - $24,766	-280 Reduced 1.25%	22,110 $1.85 Million
Q3 2019 Oct 15, 2019	BUY	$81.4 - $89.78 $106,064 - $116,983	1,303 Added 6.18%	22,390 $1.96 Million
Q2 2019 Jul 19, 2019	BUY	$73.44 - $82.41 $1.55 Million - $1.74 Million	21,087 New	21,087 $1.73 Million

1,008

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.6B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Genesee Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Genesee Capital Advisors, LLC with notifications on news.